JP2002540119A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002540119A5 JP2002540119A5 JP2000606618A JP2000606618A JP2002540119A5 JP 2002540119 A5 JP2002540119 A5 JP 2002540119A5 JP 2000606618 A JP2000606618 A JP 2000606618A JP 2000606618 A JP2000606618 A JP 2000606618A JP 2002540119 A5 JP2002540119 A5 JP 2002540119A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- ether
- ester
- compound
- configuration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- CWVMWSZEMZOUPC-JUAXIXHSSA-N (3s,5s,8r,9s,10s,13s,14s,16r)-16-bromo-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C([C@H](Br)C4)=O)[C@@H]4[C@@H]3CC[C@H]21 CWVMWSZEMZOUPC-JUAXIXHSSA-N 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12605699P | 1999-03-23 | 1999-03-23 | |
| US60/126,056 | 1999-03-23 | ||
| US14002899P | 1999-06-16 | 1999-06-16 | |
| US60/140,028 | 1999-06-16 | ||
| US41490599A | 1999-10-08 | 1999-10-08 | |
| US09/414,905 | 1999-10-08 | ||
| US16404899P | 1999-11-08 | 1999-11-08 | |
| US60/164,048 | 1999-11-08 | ||
| PCT/US2000/007883 WO2000056757A1 (en) | 1999-03-23 | 2000-03-23 | Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002540119A JP2002540119A (ja) | 2002-11-26 |
| JP2002540119A5 true JP2002540119A5 (enExample) | 2007-05-24 |
Family
ID=27494614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000606618A Pending JP2002540119A (ja) | 1999-03-23 | 2000-03-23 | 免疫修飾ステロイドとくに１６α−ブロモエピアンドロステロンのヘミハイドレート |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1163256B1 (enExample) |
| JP (1) | JP2002540119A (enExample) |
| KR (2) | KR20070007394A (enExample) |
| CN (1) | CN1243767C (enExample) |
| AP (1) | AP2001002285A0 (enExample) |
| AT (1) | ATE259825T1 (enExample) |
| AU (1) | AU781997B2 (enExample) |
| BR (1) | BR0009476A (enExample) |
| CA (1) | CA2365081A1 (enExample) |
| CZ (1) | CZ20013420A3 (enExample) |
| DE (1) | DE60008353T2 (enExample) |
| DK (1) | DK1163256T3 (enExample) |
| ES (1) | ES2215631T3 (enExample) |
| HK (1) | HK1046002B (enExample) |
| HU (1) | HUP0203429A3 (enExample) |
| IL (1) | IL144916A0 (enExample) |
| NO (2) | NO320801B1 (enExample) |
| NZ (1) | NZ513803A (enExample) |
| OA (1) | OA11850A (enExample) |
| PT (1) | PT1163256E (enExample) |
| RU (2) | RU2417792C2 (enExample) |
| WO (1) | WO2000056757A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070129282A1 (en) | 1998-11-24 | 2007-06-07 | Ahlem Clarence N | Pharmaceutical treatments and compositions |
| US6667299B1 (en) | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
| EP1228083A2 (en) | 1999-09-30 | 2002-08-07 | Hollis-Eden Pharmaceuticals Inc. | Therapeutic treatment of androgen receptor driven conditions |
| US7241753B2 (en) | 2000-02-25 | 2007-07-10 | Loria Roger M | Method of treatment of prostate cancer |
| EP1372664A1 (en) | 2001-03-01 | 2004-01-02 | Hollis-Eden Pharmaceuticals Inc. | Use of certain steroids for treatment of blood cell deficiencies |
| FR2829697B1 (fr) * | 2001-09-14 | 2004-03-19 | Mayoly Spindler Lab | Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin |
| US20040138187A1 (en) * | 2002-08-28 | 2004-07-15 | Reading Christopher L. | Therapeutic treatment methods |
| GB0304927D0 (en) | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
| RU2356555C2 (ru) * | 2003-12-26 | 2009-05-27 | Ниссан Кемикал Индастриз, ЛТД | Антинейтрофильное средство |
| MD4009C2 (ro) * | 2008-07-15 | 2010-08-31 | Институт Химии Академии Наук Молдовы | Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos |
| CN104072564B (zh) * | 2013-03-28 | 2016-08-17 | 广州市赛普特医药科技股份有限公司 | 2β,3α,5α-三羟基-雄甾-6-酮及其制备方法与用途 |
| CN106565654B (zh) * | 2016-10-14 | 2018-08-31 | 云南中烟工业有限责任公司 | 一种从白云参中提取的新型黄酮类化合物、其制备方法及其用途 |
| BR112020021278A2 (pt) * | 2018-06-01 | 2021-01-26 | Société des Produits Nestlé S.A. | butirato dietário |
| US10836788B2 (en) | 2019-02-05 | 2020-11-17 | SD Chem, Inc. | Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof |
| AU2020398693A1 (en) * | 2019-12-05 | 2022-04-28 | Société des Produits Nestlé S.A. | Dietary butyrate |
| CN114907333B (zh) * | 2022-05-11 | 2023-07-04 | 中国人民解放军军事科学院军事医学研究院 | 环丙甲酰胺衍生物及其制备方法和用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH197784A (de) * | 1934-05-25 | 1938-05-15 | Schering Kahlbaum Ag | Verfahren zu Darstellung von D5,6-trans-Androstendiol-3,17. |
| ES8706717A1 (es) * | 1983-08-02 | 1987-07-01 | Research Corp | Metodo de preparar esteroides |
| NL194728C (nl) * | 1987-04-16 | 2003-01-07 | Hollis Eden Pharmaceuticals | Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan. |
| US4910226A (en) * | 1987-04-29 | 1990-03-20 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
| JPH0289327A (ja) * | 1988-09-27 | 1990-03-29 | Matsushita Electron Corp | 銀ペースト塗布装置 |
| US5837269A (en) * | 1989-09-25 | 1998-11-17 | University Of Utah Research Foundation | Vaccine compositions and method for enhancing an immune response |
| IE60458B1 (en) * | 1989-10-26 | 1994-07-13 | Elan Corp Plc | Enhanced bioavailability adsorbates |
-
2000
- 2000-03-23 CN CNB008053669A patent/CN1243767C/zh not_active Expired - Fee Related
- 2000-03-23 DE DE60008353T patent/DE60008353T2/de not_active Expired - Lifetime
- 2000-03-23 KR KR1020067027190A patent/KR20070007394A/ko not_active Ceased
- 2000-03-23 NZ NZ513803A patent/NZ513803A/en unknown
- 2000-03-23 IL IL14491600A patent/IL144916A0/xx not_active IP Right Cessation
- 2000-03-23 OA OA1200100237A patent/OA11850A/en unknown
- 2000-03-23 BR BR0009476-5A patent/BR0009476A/pt not_active Application Discontinuation
- 2000-03-23 RU RU2006133273/04A patent/RU2417792C2/ru not_active IP Right Cessation
- 2000-03-23 HK HK02106613.2A patent/HK1046002B/zh not_active IP Right Cessation
- 2000-03-23 HU HU0203429A patent/HUP0203429A3/hu unknown
- 2000-03-23 RU RU2001128881/04A patent/RU2295534C2/ru not_active IP Right Cessation
- 2000-03-23 EP EP00918365A patent/EP1163256B1/en not_active Expired - Lifetime
- 2000-03-23 CA CA002365081A patent/CA2365081A1/en not_active Abandoned
- 2000-03-23 KR KR1020017012156A patent/KR100717897B1/ko not_active Expired - Fee Related
- 2000-03-23 CZ CZ20013420A patent/CZ20013420A3/cs unknown
- 2000-03-23 ES ES00918365T patent/ES2215631T3/es not_active Expired - Lifetime
- 2000-03-23 DK DK00918365T patent/DK1163256T3/da active
- 2000-03-23 WO PCT/US2000/007883 patent/WO2000056757A1/en not_active Ceased
- 2000-03-23 PT PT00918365T patent/PT1163256E/pt unknown
- 2000-03-23 AP APAP/P/2001/002285A patent/AP2001002285A0/en unknown
- 2000-03-23 AT AT00918365T patent/ATE259825T1/de not_active IP Right Cessation
- 2000-03-23 JP JP2000606618A patent/JP2002540119A/ja active Pending
- 2000-03-23 AU AU39190/00A patent/AU781997B2/en not_active Ceased
-
2001
- 2001-09-21 NO NO20014588A patent/NO320801B1/no not_active IP Right Cessation
-
2005
- 2005-12-23 NO NO20056167A patent/NO20056167L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002540119A5 (enExample) | ||
| JP2002533472A5 (enExample) | ||
| CA2440680A1 (en) | Steroids as agonists for fxr | |
| JP2003531118A5 (enExample) | ||
| JP2002518502A5 (enExample) | ||
| JP2003512474A5 (enExample) | ||
| JP2003525190A5 (enExample) | ||
| JP2004502638A5 (enExample) | ||
| JP2002535332A5 (enExample) | ||
| JP2003530368A5 (enExample) | ||
| JP2008512426A5 (enExample) | ||
| RU2417792C2 (ru) | Иммуномодуляторные стероиды | |
| JP2005530779A5 (enExample) | ||
| JP2002520286A5 (enExample) | ||
| JP2001520994A5 (enExample) | ||
| JP2000169325A5 (enExample) | ||
| JP2001515881A5 (enExample) | ||
| JP2003515543A5 (enExample) | ||
| JP2002541198A5 (ja) | 失禁治療用医薬組成物 | |
| JP2006518765A5 (enExample) | ||
| JP2004529960A5 (enExample) | ||
| JP2003521457A5 (enExample) | ||
| JPH1112272A5 (enExample) | ||
| SG160328A1 (en) | Adjuvant composition comprising aluminium phosphate and 3d-mpl | |
| EP1156058A3 (en) | Process for the preparation of (E,Z) 3-(2-aminoethoxyimino)-androstane-6,17-dione and its analogues |